Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery …
Illumina, Inc. (NASDAQ:ILMN) announced its financial results for the second quarter of fiscal year 2017.
Illumina, Inc. (NASDAQ:ILMN) and NRGene announced a collaboration to develop new molecular breeding tools for cattle.
With too many press releases to keep track of, here’s a running tab of the updates which we find most relevant for the …
Illumina, Inc.(NASDAQ:ILMN) announced a strategic collaboration, that aims to integrate Illumina’s sequencing systems for large-scale analysis of genetic variation and function and Philips’ …
Illumina, Inc. (NASDAQ:ILMN) announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed …
Illumina, Inc. (NASDAQ:ILMN) announced it has named one of the world’s top clinical genomics experts to head its clinical genomics unit.
Illumina, Inc. (NASDAQ:ILMN) announced the appointment of Jonathan Seaton as Senior Vice President for Corporate & Business Development, further strengthening its executive team …
Illumina, Inc. (NASDAQ:ILMN) announced the appointment of Sam A.
Illumina, Inc. (NASDAQ:ILMN) announced the launch of TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the tumor-profiling paradigm …
